Abbott acquires CFR Pharmaceuticals.

Abbott acquires CFR Pharmaceuticals; declares results of tender present for CFR’s ordinary shares Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical existence and further expanding the company's existence in fast-growing markets. Through buy of the controlling interest and tender offers referred to below, Abbott indirectly obtained a lot more than 99 % of CFR's ordinary shares for about $2.9 billion follow this site . ‘With the addition of CFR's portfolio of well-known, trusted products, Abbott has taken another key part of actively shaping its portfolio to raised meet the evolving needs of healthcare and drive sustainable growth,’ said Miles D.